Page 1 of 2
12

2025 (1 POST)

Stemer TR, Covington TR, Cowan DW, Coyle JP, Gearhart JM, LaLonde TJ, Ring CL, Sweeney LM, Wambaugh JF, Wooten AT, Bang AG, Clewell RA. Rapid risk assessment of potential neurotoxicants using non-animal test methods. Abstract 4842, Society of Toxicology 64th Annual Meeting, Orlando, FL, March 2025.

View Abstract

2022 (2 POSTS)

Allen DG, Rooney J, To K, Choksi N, Ceger P, Daniel A, et al. Variability in reference test method data and the impact on NAM evaluations. Poster presented at Society of Toxicology 61st Annual Meeting, San Diego, CA, March 2022.

View Abstract

Catalano S, Choksi N, Corvaro M, Kolle S, Stinchombe S, Latorre A, et al. Reducing animal use for eye irritation testing of agrochemicals in Brazil. Poster presented at Society of Toxicology 61st Annual Meeting, San Diego, CA, March 2022.

View Abstract

2021 (4 POSTS)

Robison TW, Heflich RH, Manjanatha MG, Elespuru R, Atrakchi A, Mei N, Ding W. 2021. Appropriate in vivo follow-up assays to an in vitro bacterial reverse mutation (Ames) test positive investigational drug candidate (active pharmaceutical ingredient), drug- related metabolite, or drug-related impurity. Mutat Res Gen Toxicol Environ Mutagen 868-869(Aug-Sept):503386; doi: 10.1016/j.mrgentox.2021.503386.

View Abstract

Wang Y, Mittelstaedt RA, Wynne R, Chen Y, Cao X, Muskhelishvili L, Davis K, Robison TW, et al. 2021. Genetic toxicity testing using human in vitro organotypic airway cultures: Assessing DNA damage with the CometChip and mutagenesis by duplex sequencing. Environ Mol Mutagen 62(5):306-318; doi: 10.1002/em22444.

View Abstract

Choksi NY, Daniel AB, Allen DG, Clippinger AJ, Kleinstreuer NC. 2021. Prospective and retrospective evaluation of the eye irritation potential of agrochemical formulations. Research Triangle Park, NC: National Toxicology Program. NICEATM Report 01.

View Abstract

O’Neil HC, Vincent MJ, Han AA, Brown SE, Hazell AM, Krieder ML, Madl AM. Hazard and risk banding framework for prioritization and bridging of e-liquids for toxicity testing. Poster presented at Society of Toxicology 60th Annual Meeting, Virtual, March 2021.

View Abstract

2020 (2 POSTS)

Choksi N, Clippinger AJ, Gehen S, Corvaro M, Kolle SN, Bentley K, et al. Developing a defined approach for eye irritation testing. Poster presented at Society of Toxicology 59th Annual Meeting, Virtual, March 2020.

View Abstract

Choksi N, Lebrun S, Nguyen M, Daniel A, DeGeorge G, Willoughby J, et al. 2020. Validation of the OptiSafe eye irritation test. Cutan Ocul Toxicol 39(3):180–192; doi: 10.1080/15569527.2020.1787431. PMID: 32586141.

View Abstract

2019 (2 POSTS)

Choksi NY, Truax J, Layton A, Matheson J, Mattie D, Varney T, et al. 2019. United States regulatory requirements for skin and eye irritation testing. Cutan Ocul Toxicol 38(2):141–155; doi: 10.1080/15569527.2018.1540494. PMID: 30418044.

View Abstract

Patlewicz G, Richard AM, Williams AJ, Grulke CM, Sams R, Lambert J, Noyes P, DeVito MJ, et al. 2019. A chemical category-based prioritization approach for selecting 75 per- and polyfluoroalkyl substances (PFAS) for tiered toxicity and toxicokinetic testing. Environ Health Perspect 127(1):14501; doi: 10.1289/EHP4555. PMID: 30632786.

View Abstract

2017 (3 POSTS)

Sheppard A, Baker E, Bermudez D, Blattner J, Boyd K, O’Neal S, Rahim T, Whittle E. Implementing an alternate testing strategy for assessing skin irritation. Abstract #2734, Society of Toxicology 56th Annual Meeting, Baltimore, MD, 2017.

View Abstract

Sheppard A, Baker E, Bermudez D, Blattner J, Boyd K, O’Neal S, Rahim T, Whittle E. Use of alternative methods to assess skin irritation of chemical mixtures. World Congress for Alternatives to Animal Testing, Seattle, WA, 2017.

Ceger P, Choksi N, Hamm J, Truax J, Daniel A, Allen D, et al. Development of a curated database of in vivo developmental toxicity data. Poster presented at Society of Toxicology 56th Annual Meeting, Baltimore, MD, March 2017.

View Abstract

2016 (2 POSTS)

Prior H, Bottomley A, Champeroux P, Cordes J, Delphy E, Dybdal N, et al. 2016. Social housing of non-rodents during cardiovascular recording in safety pharmacology and toxicology studies. J Pharmacol Toxicol Methods 81(Sep-Oct):75–87; doi: 10.1016/j.vascn.2016.03.004. PMID: 27039257.

View Abstract

Yang C, Casey W, Choksi N, Ceger P, Kleinstreuer N, Allen D, et al. An in vitro test method for screening potential androgenic agonists and antagonists in mda-kb2 cells. Poster presented at Society of Toxicology 55th Annual Meeting, New Orleans, LA, March 2016.

View Abstract

2007 (3 POSTS)

Kulpa-Eddy J, Jacobs A, Halder M, Burns T, Choksi N, Allen D, et al. Alternatives to the mouse LD50 assay for botulinum toxin testing: An ICCVAM/NICEATM/ECVAM sponsored workshop. Poster presented at the 6th World Congress on Alternatives and Animal Use in the Life Sciences, Tokyo, Japan, August 2007.

Choksi N, Haseman J, Truax J, Wnorowski G, Merkel D, Stokes W. Topical anesthetic pre-treatment in the Draize eye test: Impact on hazard classification. Poster presented at the 6th World Congress on Alternatives and Animal Use in the Life Sciences, Tokyo, Japan, August 2007.

Hinerman J, Mueser T. Protein-protein interactions between bacteriophage T4 helicase assembly protein and single-stranded DNA binding protein. Poster presented to Ohio Crystallographic Symposium Meeting, University of Toledo, Toledo, OH, fall 2007.

2006 (4 POSTS)

Tice RR, Allen DG, Choksi NY, Truax JF, Stokes WS. Evaluation of the relationship between in vivo rabbit eye test scores and their reversibility. Poster presented at Society of Toxicology 45th Annual Meeting, San Diego, CA, March 2006.

View Abstract
Page 1 of 2
12